Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

1

Revenue 2017

Humira

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humira was produced by AbbVie and Eisai.

European biosimilars hit AbbVie’s Humira revenues in Q4

European biosimilars hit AbbVie’s Humira revenues in Q4

Strong full year growth, but M&A speculation will linger. The launch of biosimilar versions of Humira saw revenues from the blockbuster drug grind to a halt in Q4. ... Nevertheless, the perilous transition away from Humira is leading many analysts to

Drug launches to watch in 2019

Drug launches to watch in 2019 Humira reached revenues of around $20bn in 2018, meaning AbbVie will soon have a very large hole in its revenues to fill. ... its own TNF inhibitor Humira (adalimumab), currently the biggest-selling drug in the world with revenues of $16bn in 2017.

NHS England sees off AbbVie's Hep C legal challenge

NHS England sees off AbbVie's Hep C legal challenge Among these is another procurement drive where AbbVie has lost out – the recent launch of biosimilar versions of its inflammation blockbuster Humira (adalimumab). ... It says it believes patients who are stable on their biologic medicine should not be

BMS and Celgene deal sparks debate on pharma profit motive, more M&A

BMS and Celgene deal sparks debate on pharma profit motive, more M&A Despite a healthy looking pipeline, AbbVie will still struggle to replace its blockbuster Humira when it loses its US patent in 2023.

Generic Differentiation

Generic Differentiation The former is evidenced, most recently, by the biosimilars piling in the moment Humira loses protection.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics